Dashboard
Manage Tickers

CLXPFCYBIN INC.

NYSE cybin.com


$ 0.34 $ 0.00 (0.29 %)    

Wednesday, 29-May-2024 10:02:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 1.03 (0.23 %)
DIA $ 398.57 $ 0.42 (0.11 %)
SPY $ 530.36 $ 0.60 (0.11 %)
TLT $ 91.26 $ -0.10 (-0.11 %)
GLD $ 225.37 $ 0.83 (0.38 %)
$ 0.3499
$ 0.34
$ 0.00 x 0
$ 0.34 x 600
$ 0.34 - $ 0.34
$ 0.21 - $ 0.74
2,780,354
na
68.35M
$ 0.49
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

what-do-you-really-know-about-psychedelics-and-psychedelics-stocks
What Do You Really Know About Psychedelics...
08/11/2021 15:18:16

According to a new poll conducted by Hill-HarrisX, 65% of registered voters say psychedelic substances do not have medical use.

cybin-becomes-first-psychedelics-company-on-the-nyse-ceo-explains-everything-you-need-to-know
Cybin Becomes First Psychedelics Company O...
08/05/2021 18:51:51

Cybin (NYSE: CYBN), a biotech company in the psychedelics space, began listing its stock on the New York Stock Exchange on Thur...

psychedelics-research-fyi-every-clinical-trial-underway-right-now-involving-public-and-private-companies
Psychedelics Research FYI: Every Clinical ...
08/03/2021 18:23:57

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In jus...

psyched-field-trip-uplists-to-nasdaq-mindmed-to-study-dmt-atai-launches-new-subsidiary-aocs-psychedelics-amendment-rejected
Psyched: Field Trip Uplists To Nasdaq, Min...
08/02/2021 14:08:33

Last week in Psychedelics:

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
07/26/2021 14:05:18

 

Core News & Articles
HC Wainwright & Co. Initiates Coverage On ...
07/26/2021 13:36:42

HC Wainwright & Co. analyst Patrick Trucchio initiates coverage on Cybin (OTC:CLXPF) with a Buy rating and announces Pri...

psyched-cybin-and-field-trip-head-to-wall-street-aoc-pushes-for-federal-psychedelics-research-off-label-ketamine-covered-by-insurance-in-canada
Psyched: Cybin And Field Trip Head To Wall...
07/26/2021 12:02:09

Cybin Inc.

field-trip-health-heads-to-the-nasdaq-as-wall-street-opens-up-to-psychedelics-renaissance
Field Trip Health Heads To The Nasdaq As W...
07/23/2021 21:04:15

Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector.

cybin-lands-conditional-approval-to-become-the-first-psychedelics-company-on-the-nyse
Cybin Lands Conditional Approval To Become...
07/22/2021 18:03:49

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF), a biotech company in the psychedelics space, announced on Thursday a conditional approva...

psyched-numinus-mindmed-cybin-reach-milestones-harvard-to-study-psychedelics-law-michael-pollan-dives-into-mescaline
Psyched: Numinus, MindMed, Cybin Reach Mil...
07/12/2021 12:41:59

Michael Pollan’s New Book Takes A Deep Dive Into Mescaline – Will This Be A Turning Point For The Recognition And Study of Mesc...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
07/08/2021 14:03:41

 

Core News & Articles
Aegis Capital Initiates Coverage On Cybin ...
07/08/2021 13:33:37

Aegis Capital analyst Nathan Weinstein initiates coverage on Cybin (OTC:CLXPF) with a Buy rating and announces Price Target ...

psychedelics-research-fyi-every-clinical-trial-underway-right-now-involving-public-and-private-companies
Psychedelics Research FYI: Every Clinical ...
07/07/2021 17:50:57

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In jus...

psyched-gh-research-debuts-on-nasdaq-compass-reaches-psilocybin-research-milestone-maxim-gives-buy-rating-to-10-psychedelics-companies
Psyched: GH Research Debuts on Nasdaq, Com...
07/02/2021 20:20:48

Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential of 5-MeO-DMT f...

maxim-group-gives-buy-rating-to-10-psychedelic-stocks-compass-mindmed-cybin-field-trip-and-more
Maxim Group Gives Buy Rating To 10 Psyched...
06/30/2021 22:14:36

Institutional analysts are taking a liking to the industry of medicinal psychedelics. This week, investment bank Maxim Group in...

cybin-inc-biotech-co-reports-51-million-in-cash-as-stifel-ups-price-target-to-12
Cybin Inc Biotech Co Reports $51 Million I...
06/29/2021 02:41:36

Psychedelics companies continue to receive welcoming signs from Wall Street. As more companies commence their Nasdaq listings, ...

psyched-atai-life-sciences-hits-nasdaq-canada-to-fund-ketamine-trials-mydecine-launches-ai-drug-discovery-platform
Psyched: Atai Life Sciences Hits Nasdaq, C...
06/21/2021 14:21:54

Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq debut on Friday.

psyched-atais-214m-ipo-mindmed-ceo-resigns-field-trip-applies-to-nasdaq-cybin-and-novamind-target-frontline-health-workers
Psyched: Atai's $214M IPO, MindMed CEO Res...
06/14/2021 13:18:12

Atai Launches $214 Million Nasdaq IPO Offering Psychedelics biotech platform Atai life Sciences has announced an initial publi...

cybin-to-co-sponsor-clinical-trial-testing-psilocybin-in-frontline-health-workers-with-covid-related-distress
Cybin To Co-Sponsor Clinical Trial Testing...
06/08/2021 21:15:21

Psychedelics and biotech company Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) is co-sponsoring a new clinical trial that will test the...

what-do-you-really-know-about-psychedelics-and-psychedelics-stocks
What Do You Really Know About Psychedelics...
06/08/2021 17:12:16

According to a new poll conducted by Hill-HarrisX, 65% of registered voters say psychedelic substances do not have medical use.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION